CompanyGraph
Gushengtang Holdings Ltd.
2273 · HKEX · China
Price data from its F2P listing on FSX, quoted in EUR
gstzy.cnFinancials as of FY2025
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleLevered free cash flow is $44.97M, above the global median of $18.73M
- FinancialsAltman Z-Score 3.04: safe zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.07%
Annual Rate
HKD 1.38Paid semi-annual
Payout Ratio
60.4%Moderate
Payback Period
2.8 yr
Last Ex-Dividend
Sep 30, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
6.78BHKD864.14M · vs all stocks (USD)
Trailing P/E
15.20xvs Medical Care Facilities peers
Revenue (TTM)
3.98BCNY507.93M · vs all stocks (USD)
Profit Margin
12.38%vs Medical Care Facilities peers
Beta
0.5810xvs all stocks
52-Week Change
-16.74%vs all stocks
Forward Annual Dividend Yield
5.07%vs all stocks
Market Capitalization
6.78BHKD864.14M · vs all stocks (USD)
Enterprise Value
7.16BHKD912.94M · vs all stocks (USD)
Trailing P/E
15.20xvs Medical Care Facilities peers
Forward P/E
10.82xvs Medical Care Facilities peers
Price to Sales (TTM)
1.68xvs Medical Care Facilities peers
Price to Book (MRQ)
2.62xvs Medical Care Facilities peers
Enterprise to Revenue
1.80xvs Medical Care Facilities peers
Enterprise to EBITDA
12.33xvs Medical Care Facilities peers
Profit Margin
12.38%vs Medical Care Facilities peers
Operating Margin
11.48%vs Medical Care Facilities peers
Return on Assets (TTM)
6.55%vs Medical Care Facilities peers
Return on Equity (TTM)
19.63%vs Medical Care Facilities peers
Revenue (TTM)
3.98BCNY507.93M · vs all stocks (USD)
Revenue per Share (TTM)
14.97CNYUpdated Sep 20, 2026Quarterly Revenue Growth
10.60%vs Medical Care Facilities peers
Gross Profit (TTM)
1.24BCNY157.53M · vs all stocks (USD)
EBITDA (TTM)
641.18MCNY81.73M · vs all stocks (USD)
Net Income (TTM)
493.34MCNY62.89M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
45.50%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
612.42MCNY78.07M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
352.76MCNY44.97M · vs all stocks (USD)
Forward Annual Dividend Rate
1.38HKDUpdated Sep 20, 2026Forward Annual Dividend Yield
5.07%vs all stocks
Trailing Annual Dividend Rate
1.04HKDUpdated Sep 20, 2026Trailing Annual Dividend Yield
3.82%vs all stocks
Payout Ratio
60.40%vs Medical Care Facilities peers
Minority Interest (Equity)
14.41MCNYFY2025 · Dec 31, 2025Revenue
3.25BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.24BCNYFY2025 · Dec 31, 2025Gross Profit
1.01BCNYFY2025 · Dec 31, 2025Operating Income
461.22MCNY68.82M · vs all stocks (USD)
Pre-tax Income
423.65MCNYFY2025 · Dec 31, 2025Income Tax Expense
71.58MCNYFY2025 · Dec 31, 2025Net Income
352.07MCNYFY2025 · Dec 31, 2025EBIT
449.80MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
641.18MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
564.34MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
26.15MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.49CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.45CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
237.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
237.36MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
696.00KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
497.36MCNYFY2025 · Dec 31, 2025Free Cash Flow
396.74MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
882.33MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
423.65MCNYFY2025 · Dec 31, 2025Stock-based Compensation
50.49MCNYFY2025 · Dec 31, 2025Other Non-cash Items
10.49MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
32.03MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-19.30MCNYFY2025 · Dec 31, 2025Capital Expenditures
-100.63MCNYFY2025 · Dec 31, 2025Net Intangibles (CF)
-15.88MCNYFY2025 · Dec 31, 2025Net Acquisitions
-101.50MCNYFY2025 · Dec 31, 2025Purchase of Investments
-839.17MCNYFY2025 · Dec 31, 2025Sale of Investments
679.59MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-361.71MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
228.18MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-21.56MCNYFY2025 · Dec 31, 2025Common Stock Repurchase
-431.93MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-163.47MCNYFY2025 · Dec 31, 2025Other Financing Charges
10.68MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-314.36MCNYFY2025 · Dec 31, 2025Shares Outstanding
225.77MSharesUpdated Sep 20, 2026Float Shares
148.44MSharesUpdated Sep 20, 2026% Held by Insiders
45.07%vs all stocks
% Held by Institutions
13.70%vs all stocks
Total Cash (MRQ)
1.38BCNY175.36M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.53CNYUpdated Sep 20, 2026Total Debt (MRQ)
1.79BCNY228.54M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8097xvs Medical Care Facilities peers
Current Ratio (MRQ)
1.18xvs Medical Care Facilities peers
Book Value per Share (MRQ)
10.33CNYUpdated Sep 20, 2026Total Assets
3.99BCNY595.76M · vs all stocks (USD)
Total Current Assets
1.86BCNYFY2025 · Dec 31, 2025Total Liabilities
1.81BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.14BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
655.98MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.15BCNYFY2025 · Dec 31, 2025Cash
881.80MCNYFY2025 · Dec 31, 2025Cash Equivalents
531.00KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
882.33MCNYFY2025 · Dec 31, 2025Other Short-term Investments
219.69MCNYFY2025 · Dec 31, 2025Accounts Receivable
257.40MCNYFY2025 · Dec 31, 2025Inventory
194.54MCNYFY2025 · Dec 31, 2025Accounts Payable
302.19MCNYFY2025 · Dec 31, 2025Short-term Debt
215.61MCNYFY2025 · Dec 31, 2025Long-term Debt
568.40MCNYFY2025 · Dec 31, 2025Common Stock (Book)
151.00KCNYFY2025 · Dec 31, 2025Retained Earnings
-786.00MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.18BCNY325.95M · vs all stocks (USD)
Treasury Stock
225.60MCNYFY2025 · Dec 31, 202552-Week Low
24.32HKDUpdated Sep 20, 202652-Week High
33.44HKDUpdated Sep 20, 202652-Week Change
-16.74%vs all stocks
Beta
0.5810xvs all stocks
50-Day MA
28.06HKDUpdated Sep 20, 2026200-Day MA
28.34HKDUpdated Sep 20, 2026Avg 10-Day Volume
471.91KSharesUpdated Sep 20, 2026Avg 30-Day Volume
684.68KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
1.78CNYUpdated Sep 20, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
How is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Drawdown With OCF Coverage And Growth Consistency
Well below its peak, with cash covering profit and growth that has been steady.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.11Receivables vs revenue divergence: 2.45
Financial Health
Altman Z-Score 3.04: safe zoneNotable
Altman Z-Score: 3.04
High structural barrier to entryNotable
Barrier to Entry: 0.66
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Levered free cash flow is $44.97M, above the global median of $18.73MNotable
Levered free cash flow (USD): 44,966,954.55Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Ncs Testing Technology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionSenseMakingProduction
Bangkok Chain Hospital Public Company Limited
Tier 1RuleThroughput-Bound ConversionProductionRisk
Chengdu Bright Eye Hospital Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionSenseMaking
New Journey Health Technology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionSenseMaking
Yatharth Hospital & Trauma Care Services Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Guangxi Radio and Television Co., Ltd.
Tier 1RuleThroughput-Bound ConversionFlowAttention
InnovAge Holding Corp.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Surfilter Network Technology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionSenseMakingProduction
Charming Medical Limited
Tier 1RuleThroughput-Bound ConversionProductionInterface
Clariane SE
Tier 1RuleThroughput-Bound ConversionProductionFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Kanzhun Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedDrawdown With FCF And Cash BackingOperating Income Growing With Multi-Year Revenue GrowthDrawdown With OCF Coverage And Growth Consistency
NerdWallet Inc.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedDrawdown With FCF And Cash BackingOperating Income Growing With Multi-Year Revenue GrowthDrawdown With OCF Coverage And Growth Consistency
eToro Group Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedDrawdown With FCF And Cash BackingDrawdown With OCF Coverage And Growth Consistency